RxDoctor Payments Data
★ My doctorsLook up a doctor →

Joyti Gore

Los Angeles, CANPI 1225711120

Payments from drug & device makers

$2,385in general payments, 2019–2025

Across 94 payments — averaging $25.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sobi, Inc$298
  • Astellas Pharma US Inc$267
  • Merck$211
  • Pfizer$193
  • Array Biopharma Inc$185
  • Johnson & Johnson$166
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,21193%
  • Education$1747%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sobi, Inc10$298
Astellas Pharma US Inc9$267
Merck8$211
Pfizer9$193
Array Biopharma Inc8$185
Johnson & Johnson6$166
Lilly USA, LLC6$109
Bayer4$106
Agios Pharmaceuticals, Inc.4$91
EMD Serono, Inc.3$89
Legend Biotech USA Inc.3$89
Karyopharm Therapeutics Inc.3$81
Pharmaessentia USA Corporation2$65
Novartis4$65
AbbVie2$53
Takeda Pharmaceuticals U.S.A., Inc.2$50
Blueprint Medicines Corporation2$49
AstraZeneca2$49
AVEO Pharmaceuticals, Inc.2$42
Spectrum Pharmaceuticals Inc.1$39
Genentech USA, Inc.1$27
Puma Biotechnology, Inc.1$26
Regeneron Healthcare Solutions, Inc.1$20
E.r. Squibb & Sons, L.L.C.1$16

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole43$289

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →